(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 6.41% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.22%.
Albemarle's revenue in 2025 is $4,993,278,000.On average, 27 Wall Street analysts forecast ALB's revenue for 2025 to be $592,886,611,416, with the lowest ALB revenue forecast at $561,818,317,368, and the highest ALB revenue forecast at $640,548,198,876.  On average, 27 Wall Street analysts forecast ALB's revenue for 2026 to be $629,839,052,064, with the lowest ALB revenue forecast at $454,373,800,452, and the highest ALB revenue forecast at $725,515,275,780.  
In 2027, ALB is forecast to generate $719,866,495,044 in revenue, with the lowest revenue forecast at $571,703,683,656 and the highest revenue forecast at $946,170,773,280.